Treating psoriasis using a small molecule inhibitor of tumor necrosis factor alpha
EP4701636A1Pending Publication Date: 2026-03-04SANOFI SA(FR)
-1 Cites -1 Cited by
Patent Information
- Application Number
- EP2024722208
- Authority / Receiving Office
- EP · EP
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2023-09-21
- Filing Date
- 2024-04-25
- Publication Date
- 2026-03-04
Abstract
Provided herein are treatments for psoriasis, wherein a human subject is administered a 400 mg daily dose of Compound 1 or a pharmaceutically acceptable salt thereof.
Need to check novelty before this filing date? Find Prior Art